Human Clinical Trials

Completed Human Trial

The Effects of Fortetropin® Supplementation on Body Composition, Strength, Power, and Serum Myostatin Level in Humans
  • Double blind, placebo controlled, randomized, parallel, 3-month of daily dosing of Fortetropin® in males. Supplement or placebo were mixed in a daily shake
  • 45 males randomized in 3 arms; age range of 19.7 ± 1.5 years; weight range of 70.6 ± 10.4 kg
  • Monitored and supervised resistance training 2x per week; Diet and nutrition monitored and controlled by a dietician
  • Primary Endpoint is measurement of skeletal muscle(quadriceps) hypertrophy
  • Secondary Endpoint is measurement of Lean Body Mass and Fat Mass
  • Tertiary Endpoint is measurement of Strength and Power
  • Serum myostatin levels at baseline and end of study

Results

No study related adverse events reported during the study

Fortetropin® Decreases Serum Myostatin Levels

Fortetropin® Decreases Serum Myostatin Levels

Fortetropin® Increases Muscle Size & Strength

Fortetropin® Increases Muscle Size & Strength